Biography
I am a Principal Scientist at the Sanofi Satellite laboratory, integrated in the Animal Cell Technology Unit of iBET’s Health & Pharma Division, where I have been working since 2019.
My research focuses on streamlining cell line development and optimizing production systems through cell engineering approaches, with a particular emphasis on recombinant adeno-associated virus (rAAV) and antibody production platforms.
My work at iBET has led to the development of scalable rAAV production platforms and sensitive analytical methods for bioprocess monitoring.
I completed my pharmaceutical studies in 2002 and an MSc in Pharmacology and Drug Discovery in 2004 at the Universitat de València, Spain. I got my doctoral degree in 2008, testing the anticancerous and anti-inflammatory properties of natural compounds. My postdoctoral work at the CRUK/MRC Institute for Radiation Oncology at the University of Oxford focused on DNA damage repair and cancer biology.
Over the past decade, I have honed my expertise in omics analysis, cell engineering, and genetics screens using high-throughput techniques. I also actively contribute to the scientific community through student supervision and reviewing manuscripts for prestigious scientific journals.
CV Highlights: More than 40 scientific meetings participations, 23 scientific publications in high impact journals such as Nature Structural Molecular Biology, EMBO or Nature Communications. More than 1500 citations with an H index =14, Two FCT projects as principal investigator, Marie Curie Fellowship (2014) and FCT investigator award (2020).